FDA Approves New Pneumococcal Vaccine for Adults
WASHINGTON, D.C. — The Food and Drug Administration (FDA) this week approved a new vaccine, Capvaxive, to combat invasive diseases and pneumonia caused by Streptococcus pneumoniae in adults. This approval …
FDA Approves New Pneumococcal Vaccine for Adults Read More